Scaleup programmes

Back to programmes

Programme

Cambridge Angels

Finance and Risk Capital

Impact for scaleups

142

UK companies backed

41%

Follow-on investments

70%

Investments outside London

65%

Growth Stage at time of Fundraising

Key sectors

Healthcare Life Sciences & Biotech Technology & Communications

Cambridge Angels is a group of more than 60 high-net-worth investors who invest in and mentor high quality early-stage and scaling companies in Cambridge, London, Oxford and throughout the UK. The network continues to focus on sectors including deep-tech, healthcare, and technologies with strong growth potential. In 2022, Cambridge Angels invested £71.2m in 58 companies.

Typical funding requirements that Cambridge Angels meet are in the range of £150k to £1.5m – although several portfolio companies have raised significant follow-on funding from its members and the network’s VC partners over several funding rounds. There is a particular focus on deep-tech, and tools and technologies supporting healthcare.

In addition to providing funding, Cambridge Angels also offers expertise, contacts and directly relevant experience to early-stage and scaling companies – in what it terms “smart capital from entrepreneurs to entrepreneurs.”

Emphasis is placed upon leveraging the collective experience of the portfolio and the angels. Sessions are hosted in which angels and a network of professionals and associates provide portfolio companies with education sessions on topics such as exits and building leadership teams.

Since inception in September 2001, Cambridge Angels has invested over £150 million in more than 120 portfolio companies. Twenty-four of the companies in the current portfolio are in the scaleup stage, having received early-stage funding and support from Cambridge Angels at their seed stage and continuing to date.

In 2024, Cambridge Angels continued to play a pivotal role in funding and mentoring early-stage companies in the UK, particularly focusing on technology, healthcare, and deep-tech sectors. The network has grown significantly, now with over 60 members, most of whom are experienced entrepreneurs themselves. The network has also seen successful exits, including the sale of Encore in September 2024. Cambridge Angels’ deep ties with the Cambridge innovation ecosystem and strong connections with venture capital partners help its portfolio companies grow rapidly and successfully.

Cambridge Angels website